PERSPECTA

News from every angle

← Back to headlines

Moderna Flu Shot Review Agreement Boosts Stock

Moderna's stock surged after the FDA reversed its stance and agreed to review the company's new flu shot.

18 Feb, 16:20 — 18 Feb, 16:20
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual82d ago

Moderna stock surges as FDA reverses course, agrees to review new flu shot

Read full article →

Related Stories

Oil Jumps Above $100 After US-Iran Talks Fail

just now

Sharplink Outlines $125 Million Galaxy Onchain Yield Fund

27m ago

Sharplink Unveils $125M Yield Fund After Reporting $686M Loss

27m ago

Tech exports boom as Mexico cements top spot in US trade

53m ago